{"id":"NCT02034019","sponsor":"Ocular Therapeutix, Inc.","briefTitle":"Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery","officialTitle":null,"status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-02","primaryCompletion":"2014-12","completion":"2015-02","firstPosted":"2014-01-13","resultsPosted":"2020-01-31","lastUpdate":"2020-01-31"},"enrollment":247,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Post Ocular Surgical Inflammation and Pain"],"interventions":[{"type":"DRUG","name":"Dexamethasone","otherNames":[]},{"type":"DRUG","name":"Punctum Plug","otherNames":[]}],"arms":[{"label":"OTX-DP (Dexamethasone Punctum Plug)","type":"ACTIVE_COMPARATOR"},{"label":"PVPP (Placebo Punctum Plug)","type":"PLACEBO_COMPARATOR"}],"summary":"To evaluate the safety and efficacy of OTX-DP as a sustained release drug (dexamethasone) depot when placed in the canaliculus of the eyelid for the treatment of post-surgical inflammation and pain in subjects who have undergone cataract extraction with intra-ocular lens implantation.","primaryOutcome":{"measure":"Absence of Cells in Anterior Chamber of the Study Eye","timeFrame":"Day 14","effectByArm":[{"arm":"OTX-DP (Dexamethasone Punctum Plug)","deltaMin":54,"sd":null},{"arm":"PVPP (Placebo Punctum Plug)","deltaMin":12,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":162},"commonTop":["inflammation"]}}